The pharma sector has been facing many regulatory issues since 2016. The industry is facing adverse conditions in both the domestic and global markets. Some of the Indian pharma giants like Lupin, Sun Pharma have seen hurdles in their business due to the stricter norms of US Food and Drugs ...
Read more: Is it time to move out of pharma sector funds?